In an industry where billions of dollars and millions of patient lives hang on launch execution, the GSK Template remains the gold standard because it answers the three fundamental questions of strategy: What is our unique value? For whom? And how will we deliver it consistently?
Current CGRP antagonists are injectable and expensive. Older oral drugs (topiramate, propranolol) have poor tolerability. Unmet need = effective, well-tolerated, affordable oral prevention. gsk template
Whether you are a product manager at a top-10 pharma company or a solo founder at a biotech startup, adopting the logic of the GSK Template—focusing first on the patient, second on the evidence, and third on the alignment—will dramatically improve your chances of commercial success. It is, quite simply, how good strategy is built. In an industry where billions of dollars and
In the high-stakes world of pharmaceutical and biotech commercialization, few tools have achieved the near-mythical status of the GSK Template . Originating from GlaxoSmithKline (GSK), one of the world’s largest vaccine and drug manufacturers, this framework has transcended its corporate birthplace to become an industry standard for product positioning, brand planning, and cross-functional alignment. Current CGRP antagonists are injectable and expensive
But what exactly is the GSK Template? It is not a piece of software or a simple checklist. It is a —a structured way of thinking that forces commercial, medical, and development teams to answer the most critical questions about a drug’s potential. At its core, the template transforms raw clinical data into compelling, patient-centric value propositions. Part I: The Anatomy of the GSK Template The classic GSK Template is organized into a series of interconnected modules, typically presented as a slide deck or a living document. Each module builds upon the previous one, ensuring a logical flow from disease understanding to brand tactics.